Research Correspondence

DOI: 10.4244/EIJ-D-25-00319

Phenotyping coronary microvascular dysfunction endotypes using invasive exercise stress testing

Ghilas Rahoual1, MD; Niki Procopi1, MD; Frederic Beaupré1, MD; Maxime Michon1, MD; Clelia Martinez1, RN; Paul Guedeney1, MD, PhD; Nadjib Hammoudi1, MD, PhD; Stéphane Hatem1, MD, PhD; Eric Vicaut2, MD, PhD; Mathieu Kerneis1, MD, PhD; Johanne Silvain1, MD, PhD; Gilles Montalescot1, MD, PhD; Michel Zeitouni1, MD, PhD; on behalf of the ACTION Study Group

Coronary microvascular dysfunction (CMD) results from architectural abnormalities or the inability of the coronary microvasculature to vasodilate, both leading to angina, dyspnoea or reduced exercise capacity1. Understanding CMD mechanisms is crucial for developing targeted therapies and improving prognosis. Two CMD endotypes, “structural” and “functional”, were recently identified through the combined assessment of coronary flow reserve (CFR) and minimal microvascular resistance using bolus thermodilution with adenosine-induced hyperaemia2. This study aims to characterise different CMD phenotypes by assessing adaptation to incremental cycling exercise in the cath lab among participants with suspected angina with non-obstructive coronary artery disease (ANOCA).

Absolute microvascular resistance (Rμ), absolute coronary blood flow (Q), microvascular resistance reserve (MRR) and CFR were measured in the left anterior descending artery (LAD) using continuous thermodilution. Saline was infused at 10 mL/min (rest) and at 20 mL/min (hyperaemia) to assess MRRsaline. The presence of CMD was defined as an MRRsaline <2.33. Hyperaemic Rμ was classified as normal (<500 Wood units [WU]) or elevated (≥500 WU) based on saline-induced hyperaemia4. In addition, patients performed the cycling exercise using a supine cycling...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 24
Dec 15, 2025
Volume 21 Number 24
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-24-00247 Aug 19, 2024
Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA
Zeitouni M et al
free

Original Research

10.4244/EIJ-D-25-00277 Sep 1, 2025
Chest pain patterns and coronary microvascular function in non-obstructive coronary artery disease
Nogami K et al

Editorial

10.4244/EIJ-E-25-00037 Sep 1, 2025
Angina and coronary microvascular dysfunction: unravelling the links
Berry C and Hanna R
free

Editorial

10.4244/EIJ-E-22-00033 Oct 21, 2022
Some endotypes of microvascular dysfunction may be more worrisome than others
Maas A and Damman P
free

Original Research

10.4244/EIJ-D-25-00229 Aug 18, 2025
Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction
Mahendiran T et al

Editorial

10.4244/EIJ-E-22-00056 Feb 6, 2023
ResETTing the diagnostic utility of exercise tolerance testing for INOCA
Ali ZA and Jeremias A
free

10.4244/EIJV14I5A89 Aug 3, 2018
Microvascular disease, what little we know
Appelman Y
free

Editorial

10.4244/EIJ-D-25-01153 Jan 5, 2026
Computed tomography angiography-derived microvascular resistance: is less always more?
Gallinoro E and Barbato E
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved